Clinical Trial

WATER IV Prostate Cancer

Study acronym: WATER IV PCa
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-05
Trial Details
NCT Number NCT06651632
Lead Sponsor PROCEPT BioRobotics
Conditions Localized Prostate Cancer
Enrollment 280 participants
Start Date 2025-02-03
Primary Completion 2027-07 (estimated)
Study Completion 2037-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04